The AMPK pathway in fatty liver disease

Area of Science:

• Biochemistry
• Cell Biology
• Hepatology

Background:

• Lipid metabolism disorders are central to fatty liver diseases (FLD), including non-alcoholic (NAFLD) and alcoholic (AFLD).
• The AMP-activated protein kinase (AMPK) signaling pathway is crucial for managing lipid metabolism and preventing liver injury.

Purpose of the Study:

• To review recent research on the AMPK pathway's role in FLD.
• To detail AMPK signaling axes, their mechanisms, and therapeutic potential for liver disorders.

Main Methods:

• Literature review of studies on AMPK pathway activation and its effects on lipid metabolism in FLD models.
• Analysis of gene expression changes related to fatty acid synthesis and oxidation.

Main Results:

• AMPK activation inhibits fatty acid and cholesterol synthesis by down-regulating genes like FAS, SREBP-1c, ACC, and HMGCR.
• AMPK increases fatty acid oxidation and lipid decomposition via genes such as CPT1, PGC1, HSL, and ATGL.
• Upregulating AMPK alleviates FLD in various models, including those induced by alcohol, insulin resistance, type 2 diabetes, and obesity.

Conclusions:

• AMPK activation is a potential therapeutic target for liver disorders, particularly FLD.
• Modulating AMPK signaling can restore lipid balance and reduce liver inflammation and oxidative stress.